Oxaliplatin and Revlimid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Oxaliplatin (oxaliplatin) and Revlimid (lenalidomide). Common drug interactions include white blood cell count decreased among females and thrombocytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Oxaliplatin and Revlimid. It is created by eHealthMe based on reports of 119 people who take the same drugs from the FDA, and is updated regularly.
What is Oxaliplatin?
Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
119 people who take Oxaliplatin and Revlimid together, and have interactions are studied.
What are the common drug interactions of Oxaliplatin and Revlimid, by gender? *
What are the common drug interactions of Oxaliplatin and Revlimid, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Oxaliplatin and Revlimid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Oxaliplatin (72,058 reports)
- Revlimid (378,026 reports)
Browse all drug interactions of Oxaliplatin and Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Oxaliplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxaliplatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Revlimid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on oxaliplatin and lenalidomide (the active ingredients of Oxaliplatin and Revlimid, respectively), and Oxaliplatin and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Remicade cause Bone Pain Aggravated? - 2 seconds ago
- Drug interactions of Oxycontin and Caffeine - 10 seconds ago
- Drug interactions of Zofran and Turalio - 16 seconds ago
- Could Clonidine cause Photophobia? - 16 seconds ago
- Drug interactions of Nucynta and Zocor - 19 seconds ago
- Drug interactions of Clobetasol Propionate and Aspirin - 24 seconds ago
- Drug interactions of Meloxicam and Kombiglyze Xr - 28 seconds ago
- Drug interactions of Clobazam and Singulair - 29 seconds ago
- Drug interactions of Ornithine and Enoxaparin Sodium - 31 seconds ago
- Drug interactions of Clobazam and Donepezil - 38 seconds ago